Related Experiment Video
Updated: Oct 27, 2025
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.4K
A functionally improved case of obstructive impairment caused by systemic lupus erythematosus
Chisato Kamimaki1, Masaki Yamamoto1, Tomoe Sawazumi2
1Respiratory Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
Breathe (Sheffield, England)
|July 23, 2021
Summary
Pulmonary lymphoproliferative diseases frequently coexist with collagen diseases. Treatment requires addressing the primary condition and considering specific pathological findings.
Area of Science:
- Pulmonary Medicine
- Rheumatology
- Pathology
Background:
- Pulmonary lymphoproliferative diseases (PLD) are a group of lung disorders characterized by the proliferation of lymphoid cells.
- These conditions often exhibit a strong association with systemic autoimmune diseases, commonly referred to as collagen diseases.
Purpose of the Study:
- To highlight the frequent association between pulmonary lymphoproliferative diseases and collagen diseases.
- To emphasize the importance of tailored treatment strategies based on individual pathological presentations.
Main Methods:
- Review of existing literature and case studies on pulmonary lymphoproliferative diseases and collagen diseases.
- Analysis of treatment outcomes based on specific pathological findings in affected patients.
Main Results:
- A significant correlation exists between PLD and various collagen diseases.
- Treatment efficacy varies depending on the specific pathology and the underlying collagen disease.
Conclusions:
- Management of PLD necessitates a comprehensive approach, including treatment of the associated collagen disease.
- Personalized therapeutic interventions, guided by detailed pathological assessment, are crucial for optimal patient outcomes.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.4K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.4K
01:26COPD: Management Using Bronchodilators and Corticosteroids
498
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
498
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
01:22Chronic Obstructive Pulmonary Disease
1.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.6K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.8K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.8K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.7K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.7K